New resources to support increased access to injectable opioid agonist treatment (iOAT)

Addictions and Mental Health Ontario (AMHO) is pleased to announce new resources available to support increased access to injectable opioid agonist treatment (iOAT) in Ontario. iOAT is an evidence based and cost-effective medical intervention that is recommended for people with severe opioid dependence who have not responded to oral opioid agonist treatment (i.e., buprenorphine/naloxone and or methadone) or for whom oral opioid agonist treatment is not appropriate.

These resources were developed as part of a three-year project led by AMHO, with funding from Health Canada’s Substance Use and Addictions Program (SUAP). The goals of the project were to help decision makers determine the need to expand access to iOAT programs in Ontario and to develop resources to support increased access where the need is identified. 

These resources can be accessed on the AMHO website.


iOAT Snapshots

iOAT Resource Compendium

This compilation of resources includes links to research and policy literature about iOAT; clinical and operational resources; and information and resources about how to effectively partner with people with lived/living experience of substance use in order to plan, implement and evaluate iOAT programs in Ontario.
Compendium of Resources to Support the Implementation of Injectable Opioid Agonist Treatment (iOAT) in Ontario / Répertoire des ressources utiles pour la mise en œuvre du traitement par agoniste opioïde injectable (TAOi) en Ontario 

Project summary

This slide deck provides an overview of the AMHO iOAT project, including the main findings based on consultations with over 100 stakeholders across Ontario, and recommended goals for knowledge translation to increase access to iOAT in Ontario.
Planning for the appropriate use of prescription diacetylmorphine in Ontario / Planifier l'utilisation appropriée de la diacétylmorphine d'ordonnance en Ontario

Coming soon!

AMHO is producing a brief video clip about iOAT to increase awareness of iOAT as an effective medical treatment. It will feature the only formal iOAT program currently available in Ontario.

Any questions about the project or material can be directed to policy [at] amho [dot] ca. AMHO looks forward to collaborating with sector partners as we work to expand the number of treatment options available to Ontarians.

AMHO would like to thank the members of its project Advisory Committee for their expertise and dedication to this work and in particular to the members of the committee with lived/living experience of substance use. We would also like to acknowledge the work of the Canadian Research Institute on Substance Misuse (CRISM). CRISM’s national iOAT guidelines as well as the results of its national environmental scan of iOAT programs were both critical inputs into this project.

Sign up for our Newsletter